134 related articles for article (PubMed ID: 1888423)
1. [The blood level of gamma-aminobutyric acid in patients with liver cirrhosis and portacaval anastomosis].
Kretz FJ; Löscher W; Dillinger U
Anaesthesiol Reanim; 1991; 16(3):169-74. PubMed ID: 1888423
[TBL] [Abstract][Full Text] [Related]
2. Reversal of chronic hepatic encephalopathy by colonic exclusion: poor correlation with blood GABA levels.
Thirlby RC; Fenster LF; Coatsworth JJ; Petty F
Am J Gastroenterol; 1990 Dec; 85(12):1637-41. PubMed ID: 2252033
[TBL] [Abstract][Full Text] [Related]
3. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy.
Minuk GY; Winder A; Burgess ED; Sarjeant EJ
Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811
[TBL] [Abstract][Full Text] [Related]
4. Marked increases of plasma gamma-aminobutyric acid concentrations in cirrhotic patients with portacaval shunts are not associated with alterations of cerebral functions.
Löscher W; Kretz FJ; Karavias T; Dillinger U
Digestion; 1991; 49(4):212-20. PubMed ID: 1797600
[TBL] [Abstract][Full Text] [Related]
5. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
Levy LJ; Losowsky MS
Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
[TBL] [Abstract][Full Text] [Related]
6. Reduction of highly elevated plasma levels of gamma-aminobutyric acid does not reverse hepatic coma.
Löscher W; Kretz FJ; Tung LC; Dillinger U
Hepatogastroenterology; 1989 Dec; 36(6):504-5. PubMed ID: 2613172
[TBL] [Abstract][Full Text] [Related]
7. [Association of plasma ammonia and GABA levels and the degree of hepatic encephalopathy].
Campollo O; MacGillivray BB; McIntyre N
Rev Invest Clin; 1992; 44(4):483-90. PubMed ID: 1485027
[TBL] [Abstract][Full Text] [Related]
8. [Late results of portacaval anastomosis in liver cirrhosis].
Rapant V; Hauftová D
Cas Lek Cesk; 1969 Jul; 108(33):969-74. PubMed ID: 5800391
[No Abstract] [Full Text] [Related]
9. [Latero-lateral portocaval anastomosis with minimally-regulated flow. Value of the conservation of the hepatopetal portal flow].
Marion P; Balique JG; George M
Chirurgie; 1980; 106(3):234-6. PubMed ID: 7389507
[No Abstract] [Full Text] [Related]
10. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
Orloff MJ; Orloff MS; Orloff SL; Girard B
J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
[TBL] [Abstract][Full Text] [Related]
11. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors.
Roy S; Pomier-Layrargues G; Butterworth RF; Huet PM
Hepatology; 1988; 8(4):845-9. PubMed ID: 2839406
[TBL] [Abstract][Full Text] [Related]
12. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
Jones EA; Schafer DF; Ferenci P; Pappas SC
Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394
[TBL] [Abstract][Full Text] [Related]
13. Evidence for gamma-aminobutyric acid as the inhibitor of gamma-aminobutyric acid binding in the plasma of humans with liver disease and hepatic encephalopathy.
Levy LJ; Leek J; Losowsky MS
Clin Sci (Lond); 1987 Nov; 73(5):531-4. PubMed ID: 3677559
[TBL] [Abstract][Full Text] [Related]
14. Liver function and encephalopathy after partial vs direct side-to-side portacaval shunt: a prospective randomized clinical trial.
Capussotti L; Vergara V; Polastri R; Bouzari H; Galatola G
Surgery; 2000 Jun; 127(6):614-21. PubMed ID: 10840355
[TBL] [Abstract][Full Text] [Related]
15. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
Knudsen GM; Schmidt J; Almdal T; Paulson OB; Vilstrup H
Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
18. Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.
Snady H; Lieber CS
Am J Gastroenterol; 1988 Mar; 83(3):249-55. PubMed ID: 3344727
[TBL] [Abstract][Full Text] [Related]
19. [The future of surgical patients with portacaval anastomosis (study of the long-term resuls with 100 surgical patients between 1959 and 1964)].
Fouet P; Hivet M; Chevrel JJ
Sem Hop; 1968 May; 44(23):1586-90. PubMed ID: 4302320
[No Abstract] [Full Text] [Related]
20. [Toxic metabolites in the brain of patients with liver cirrhosis and portocaval shunt].
Lesch P
Dtsch Med Wochenschr; 1973 Oct; 98(41):1929-31. PubMed ID: 4758621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
